Suzanne L. Topalian
Distinguished in Melanoma

Dr. Suzanne L. Topalian

Surgical Oncology
Johns Hopkins Medicine
The Johns Hopkins Hospital
Baltimore, MD 

Distinguished in Melanoma
Johns Hopkins Medicine
The Johns Hopkins Hospital
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Topalian is a physician-scientist whose studies of anti-tumor immunity have been foundational in developing cancer immunotherapy. She has published over 160 original research articles and reviews in this area and is one of the most highly cited researchers in the biomedical field. She received her medical and scientific training at Tufts University School of Medicine, Thomas Jefferson University Hospital, Children’s Hospital of Philadelphia and the National Cancer Institute. She joined the Johns Hopkins Kimmel Cancer Center in 2006 as the inaugural director of its Melanoma Program. Dr. Topalian is credited with advancing the clinical development of anti-PD-1 immunotherapy, and her work is widely recognized. She was named one of Nature’s 10 in 2014, and received the Karnofsky Award from ASCO in 2015, the Taubman Prize in 2016, the NCI’s Rosalind E. Franklin Award in 2018, the American Academy of Dermatology’s Gruber Memorial Cancer Research Award in 2020, and the Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2021 for landmark discoveries in cancer immunotherapy. Dr. Topalian was elected to the National Academy of Medicine in 2017, and to the American Association for Cancer Research Academy in 2022. Her work has opened new avenues of scientific investigation and established immunotherapy as a pillar of oncology.

Dr. Topalian is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Anal Cancer.

Her clinical research consists of co-authoring 77 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 30 articles and participated in 1 clinical trial in the study of Melanoma.

Residency
Sidney Kimmel Medical College, General Surgery, 1985
Specialties
Surgical Oncology
Licenses
Surgery in MD
Fellowships
National Institutes of Health-NIH, Surgical Oncology, 1989
Languages Spoken
English
French
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO

Locations

The Johns Hopkins Hospital
Baltimore, MD 21287
Call: 410-955-5000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

In Situ Vaccination With Stereotactic Body Radiation Therapy (SBRT) as a Strategy to Overcome Resistance to Immune Checkpoint Blockade: a Phase II Clinical Trial of SBRT and Anti-PD-1 Therapy With Immunologic Correlates
In Situ Vaccination With Stereotactic Body Radiation Therapy (SBRT) as a Strategy to Overcome Resistance to Immune Checkpoint Blockade: a Phase II Clinical Trial of SBRT and Anti-PD-1 Therapy With Immunologic Correlates
Enrollment Status: Withdrawn
Publish Date: April 12, 2021
Intervention Type: Radiation, Drug
Study Drug: Nivolumab Intravenous Solution [OPDIVO]
Study Phase: Phase 2

77 Total Publications

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 31, 2025
View All 77 Publications
Similar Doctors
Francesco M. Marincola
Distinguished in Melanoma
Dr. Francesco M. Marincola
Surgical Oncology
Distinguished in Melanoma
Dr. Francesco M. Marincola
Surgical Oncology
9000 Rockville Pike, 
Bethesda, MD 
 (34.0 miles away)
301-451-4967
Languages Spoken:
English
See accepted insurances

Francesco Marincola is a Surgical Oncologist in Bethesda, Maryland. Dr. Marincola is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Breast Cancer, Colorectal Cancer, and Gliomatosis Cerebri.

Julie R. Lange
Distinguished in Melanoma
Dr. Julie R. Lange
Surgical Oncology
Distinguished in Melanoma
Dr. Julie R. Lange
Surgical Oncology

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 8, Floor 8, 
Baltimore, MD 
 (1.2 miles away)
443-997-1508
Languages Spoken:
English
See accepted insurances

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.

Distinguished in Melanoma
Dr. Edward C. Mccarron
General Surgery | Surgical Oncology
Distinguished in Melanoma
Dr. Edward C. Mccarron
General Surgery | Surgical Oncology

Medstar Medical Group Ii LLC

1406 Crain S Hwy 106, 
Glen Burnie, MD 
 (10.5 miles away)
410-768-6440
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Edward Mccarron is a General Surgeon and a Surgical Oncologist in Glen Burnie, Maryland. Dr. Mccarron is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Familial Pancreatic Cancer, Ogilvie Syndrome, Hernia Surgery, and Pancreatectomy. Dr. Mccarron is currently accepting new patients.

VIEW MORE MELANOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Topalian's expertise for a condition
ConditionClose
    • Distinguished
    • Melanoma
      Dr. Topalian is
      Distinguished
      . Learn about Melanoma.
      See more Melanoma experts
    • Merkel Cell Carcinoma
      Dr. Topalian is
      Distinguished
      . Learn about Merkel Cell Carcinoma.
      See more Merkel Cell Carcinoma experts
    • Advanced
    • Neuroendocrine Tumor
      Dr. Topalian is
      Advanced
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    • Experienced
    • Anal Cancer
      Dr. Topalian is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.